Antibody-like proteins that capture and neutralize SARS-CoV-2

To combat severe acute respiratory syndrome–related coronavirus 2 (SARS-CoV-2) and any unknown emerging pathogens in the future, the development of a rapid and effective method to generate high-affinity antibodies or antibody-like proteins is of critical importance. We here report high-speed in vitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, T., Iwatani, Y., Matsuoka, K., Fujino, T., Umemoto, S., Yokomaku, Y., Ishizaki, K., Kito, S., Sezaki, T., Hayashi, G., Murakami, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556756/
https://www.ncbi.nlm.nih.gov/pubmed/32948512
http://dx.doi.org/10.1126/sciadv.abd3916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556756/
https://www.ncbi.nlm.nih.gov/pubmed/32948512
http://dx.doi.org/10.1126/sciadv.abd3916

Ejemplares similares